• HOME
• ABOUT US
  • Company Profile
  • CRO's & Pharmaceutical Companies
• COMPANY BIOS
  • Jeff Stein
  • David M. Radin, MD
  • Judith Dalgin
  • Svetlana Konnov, LPN
  • Betsy Kempner, RN
  • Patrick Brew, MD, RN
  • Tulie Brew, MD
  • Anju Sherstha, MD
• CURRENT TRIALS
  • Chronic Lower Back Pain
  • Chronic Pain
  • Interstitial Cystitis / Painful Bladder Syndrome
  • Osteoarthritis
• CONDITIONS
• CONTACT US

Chronic Obstructive Pulmonary Disease (COPD)

Chronic obstructive pulmonary disease, or COPD, refers to chronic bronchitis and emphysema which are co-existing diseases of the lungs when the airways become narrowed. The disease is also known as chronic obstructive lung disease (COLD), chronic obstructive airway disease (COAD), chronic airflow limitation (CAL) and chronic obstructive respiratory disease.

COPD is commonly caused by smoking that leads to inflammatory responses in the lungs. Other causes include occupational exposures such as mining and welding, air pollution, and genetic susceptibility. COPD is diagnosed via a lung function test.

Possible symptoms of chronic obstructive pulmonary disease may include:

• Shortness of Breath (dyspnea)
• Persistent Cough
• Sputum or Mucus Production
• Chest Tightness
• Tiredness
• Rapid Breathing Rate (Tachypnea)
• Wheezing
• Enlargement of the Chest
• Respiratory Failure

Sorry, Stamford Therapeutics Consortium is not currently conducting a study in this category. Please check back, as we are adding new studies all the time. You can also feel free to contact Judy Dalgin our Site Manager for more information about upcoming trials.

Judy Dalgin (Site Manager)
email: jdalgin@stctrials.com
telephone: 203-325-8529